James McGlone is listed as an executive officer and director on 5 SEC Form D filings by 1 issuer between May 2020 and Dec 2023: VITARA BIOMEDICAL, INC. (Philadelphia, PA — biotechnology — 2020–2023; $40M reported sold to 9 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Diem Nguyen (5 shared filings), Thomas Todorow (5 shared filings), Bernard Lyons (4 shared filings), Ian Ratcliffe (4 shared filings), John Kelly (4 shared filings) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around James. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 5 bankruptcy cases matching the name listed in Key records below.
What this means 5 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 5 public filings for James McGlone and found 5 differences: Form D filed 21 days after the first sale; Offering amount changed between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.